BCM
BDSI

Brookstone Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Brookstone Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,427
Closed -$58K – 800
2021
Q2 		$58K Buy
15,427
+634
+4% +$2.24K ﹤0.01% 702
2021
Q1 		$58K Buy
+14,793
New +$61.1K ﹤0.01% 495

Other funds holding BDSI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Brookstone Capital Management's BDSI Position: Q3 2021 in Review

Brookstone Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2021, closing a stake of 15,427 shares — an estimated $58K sold.

Brookstone Capital Management first reported a position in BDSI in Q1 2021 and held it in 2 quarters. The position peaked at $58K in Q2 2021. 151 funds tracked by Wall St. Rank hold BDSI as of Q3 2021.

  • Brookstone Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2021 after selling out during the quarter.
  • Brookstone Capital Management sold 15,427 BioDelivery Sciences International, Inc. shares in Q3 2021, an estimated $58K.
  • Brookstone Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q1 2021 and held it in 2 quarters.
  • Brookstone Capital Management's BioDelivery Sciences International, Inc. position peaked at $58K in Q2 2021.
  • 151 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2021.

Based on Brookstone Capital Management's 13F filing for Q3 2021, filed 3 Nov 2021.